Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2002
01/23/2002EP1049744B1 Asymmetric cyanine dye quenchers
01/23/2002EP0904269B1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
01/23/2002EP0846693B1 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
01/23/2002EP0687265B1 Heterocyclic compounds and their preparation and use
01/23/2002CN1332742A Epothilone derivatives and their use as antitumor agents
01/23/2002CN1332737A Thrombin inhibitors
01/23/2002CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
01/23/2002CN1078209C Substituted thiophene derivatives and plant disease prevention and control agent containing same
01/22/2002US6340759 Fused pyridine derivatives
01/22/2002US6340758 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
01/22/2002US6340697 Oxime derivatives and agricultural chemicals containing the same
01/22/2002US6340684 Phthalazine derivatives as phosphodiesterase 4 inhibitors
01/22/2002US6340683 Selective NPY (Y5) antagonists (triazines)
01/22/2002US6340678 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them
01/17/2002WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
01/17/2002WO2002004427A1 Phenylpyridazine derivatives and drugs containing the same
01/17/2002WO2002004425A2 Viral polymerase inhibitors
01/17/2002WO2002004424A1 Pyrazole derivatives
01/17/2002WO2002004420A1 Piperidine coumpounds for use as ccr-3 inhibitors
01/17/2002WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
01/17/2002US20020007075 Neurological disorders including physically damaged nerves and neurodegenerative diseases, and for treating alopecia and promoting hair growth; Alzheimer's, Parkinson's disease; amyotrophic lateral sclerosis
01/17/2002US20020007071 Treating disorders which include neuropeptide Y excess; antagonists, antagonism
01/17/2002US20020007065 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
01/17/2002US20020006929 Antiarrhythmia agent, antiproliferative agent
01/17/2002DE10032132A1 Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung A dermal therapeutic system containing NSAIDs with selective COX-2 inhibition
01/17/2002CA2415492A1 Pyrazole derivatives
01/17/2002CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
01/17/2002CA2413042A1 Phenylpyridazine derivatives and drugs containing the same
01/16/2002EP1172362A1 Azadioxacycloalkenes and their use as fungicides and animal pesticides
01/16/2002EP1171437A1 Pesticidal indazole or benzotriazole derivatives
01/16/2002EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands
01/16/2002EP1171427A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds
01/16/2002EP1171122A1 Pyrrolidine modulators of chemokine receptor activity
01/16/2002EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors
01/16/2002CN1331690A 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders
01/16/2002CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
01/15/2002US6339101 Administering n-linked sulfonamide of an n-heterocyclic carboxylic acid derivative for therapy of nerve-related vision disorder, improving vision, therapy memory impairment or enhancing memory performance in an animal
01/15/2002US6339094 2-acylaminopropanamines as tachykinin receptor antagonists
01/15/2002US6339083 Multiheterocyclic pharmAceuticals
01/15/2002US6339046 Pyrazde herbicides
01/10/2002WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
01/10/2002WO2002002561A1 NOVEL 1β-METHYLCARBAPENEM DERIVATIVES AND PROCESS OF PREPARATION THEREOF
01/10/2002WO2002002555A1 Novel isoxazolinone antibacterial agents
01/10/2002WO2002002552A1 Quinazoline ditosylate salt compounds
01/10/2002WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
01/10/2002WO2002002550A1 Novel pyrazinone derivatives
01/10/2002WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives
01/10/2002WO2002002542A1 Five-membered-ring compound
01/10/2002WO2002002540A1 Benzoxazole compound, process for producing the same, and herbicide
01/10/2002WO2002002538A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen
01/10/2002WO2002002533A1 Propane-1,3-dione derivatives
01/10/2002WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
01/10/2002WO2002002524A1 Pyrrole derivatives for treating aids
01/10/2002WO2002002111A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
01/10/2002WO2001056993A3 Pyrazole compositions useful as inhibitors of erk
01/10/2002WO2001000615A8 Respiratory syncytial virus replication inhibitors
01/10/2002US20020004513 Azacyclic compounds
01/10/2002US20020004503 Viricides
01/10/2002US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
01/10/2002US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders
01/10/2002CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
01/10/2002CA2413245A1 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
01/10/2002CA2413002A1 Novel pyrazinone derivatives
01/10/2002CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives
01/10/2002CA2412270A1 Pyrrole derivatives for treating aids
01/09/2002EP1170289A2 Retroviral protease inhibiting compounds
01/09/2002EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof
01/09/2002EP1170009A2 Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists
01/09/2002EP1169311A1 Oxazole and thiazole combinatorial libraries
01/09/2002EP1169308A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
01/09/2002EP1169298A2 Pharmaceutical compounds
01/09/2002EP1169294A2 Pharmaceutical compounds
01/09/2002EP1169038A1 Cyclic protein tyrosine kinase inhibitors
01/09/2002EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
01/09/2002EP0937072B1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABA A alpha5 RECEPTOR SUBTYPE
01/09/2002EP0791034B1 Methine and azamethine dyes made from trifluoromethylpyridones
01/09/2002CN1330649A Herbicidal-3-[benzo(ox/thi)azol-7-yl)-1H-pyrimidine-2,4-diones
01/09/2002CN1330638A Substituted benzo (de) isoquinoline-1,3-diones
01/09/2002CN1330634A Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
01/09/2002CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their
01/08/2002US6337341 1,2,3-Thiadiazole derivatives or salts thereof and agrohorticultural disease controller
01/08/2002US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
01/08/2002CA2073981C 2-arylthiazole derivatives and pharmaceutical composition thereof
01/03/2002WO2002000651A2 Factor xa inhibitors
01/03/2002WO2002000649A1 Substituted quinazoline derivatives and their use as inhibitors
01/03/2002WO2002000647A1 Heteroaryl-phenyl substituted factor xa inhibitors
01/03/2002WO2002000633A1 Quinolinyl and benzothiazolyl ppar-gamma modulators
01/03/2002WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase
01/03/2002WO2002000606A1 Biphenyl compound
01/03/2002WO2001070870A3 Pyrimidine derivatives as hardness stabilizers
01/03/2002WO2000061549A3 Pharmaceutical compounds
01/03/2002US20020002194 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
01/03/2002US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition
01/03/2002US20020002162 Synergistic methods and compositions for treating cancer
01/03/2002DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL
01/03/2002DE10029371A1 Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka Heterocyclic Aminoalkylpyridinderivate as psychotropic drugs
01/03/2002DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin
01/03/2002CA2412592A1 Substituted quinazoline derivatives and their use as inhibitors
01/03/2002CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase
01/03/2002CA2409762A1 Heteroaryl-phenyl substituted factor xa inhibitors